
Merck Announces Formation of Merck Digital Ethics Advisory Panel
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
SpaceX launched its 21st commercial resupply mission to the International Space Station at 11:17 a.m. EST Dec. 6, 2020, from Launch Pad 39A at NASA’s […]
Merck and Artios today announced a global three year strategic research collaboration to discover and develop multiple precision oncology drugs. • Merck and Artios will […]
The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]
To create a more robust mandate for coordination by the Commission and EU agencies, the Commission is today proposing a new Regulation on serious cross-border […]
The European Centre for Disease Control and Prevention and the European Medicines Agency have been at the forefront of the EU’s work to address COVID-19 […]
Today, the European Commission is taking the first steps towards building the European Health Union announced by President von der Leyen in her State of […]
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that results from three clinical and preclinical studies have been accepted for presentation at the […]
Bayer has entered into an exclusive global license agreement with Systems Oncology, LLC, for ERSO™, a compound in pre-clinical development for the treatment of metastatic […]
• Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for people with RET-altered non-small cell lung cancer, […]
Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary […]
…. regardless of PD-L1 status, as initial treatment for people with early triple-negative breast cancer • IMpassion031 data will be discussed with health authorities globally, […]
Copyright © 2021 | WordPress Theme by MH Themes